Essen

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of Ultomiris® (Ravulizumab) Safety in Pregnancy	CNS demyelinating autoimmune disease, Cytopenia, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hemic and Lymphatic Diseases, Hemoglobinuria, Paroxysmal, Male Urogenital Diseases, Neoplasms by Site, Paraneoplastic Syndromes, Nervous System, Urogenital Diseases, acute transverse myelitis, anemia, atypical hemolytic-uremic syndrome, autoimmune disease, autoimmune disorder of the nervous system, blood platelet disease, bone marrow disorder, cranial nerve neuropathy, demyelinating disease, eye disorder, hematologic disorder, hemolytic anemia, hemolytic-uremic syndrome, immune system disorder, kidney disorder, myasthenia gravis, myelodysplastic syndrome, neoplasm, nervous system disorder, neurodegenerative disease, neuromuscular disease, neuromuscular junction disease, neuromyelitis optica, optic nerve disorder, optic neuritis, paraneoplastic syndrome, thrombocytopenia, thrombotic microangiopathy, uremia, urinary system disorder	Recruiting	Not stated	2026-04-16		NCT06312644

Clinical trials